Swedish investment firm Summa Equity acquired 75 percent of STIM in March.
STIM, based by Jim-Roger Nordly, constructed a NOK 500 million ($56 million/€47 million) facility to develop an organism that might be key to lowering antibiotic-resistant micro organism in farmed fish and different animals.Picture: Bent-Are Jensen